Effectiveness of barrier precautions and surveillance cultures to control transmission of multidrug-resistant organisms: A systematic review of the literature

American Journal of Infection Control

Volumn 34, Issue 8, 2006, Pages 484-494

  Aboelela, Sally W ^a,b   Saiman, Lisa ^c,d   Stone, Patricia ^b   Lowy, Franklin D ^a,d   Quiros, Dave ^b   Larson, Elaine ^a,b,e  

^a Center for Interdisciplinary Research on Antimicrobial Resistance (CIRAR)   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c Department of Pediatrics ^*

^d Columbia University ^*  (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; HEALTH CARE UTILIZATION; HEALTH SERVICE; HOSPITAL COST; HUMAN; INFECTION CONTROL; MEDICAL LITERATURE; MEDICAL RESEARCH; MULTIDRUG RESISTANCE; OUTCOME ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; SYSTEMATIC REVIEW;

BACTERIA; BACTERIAL INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INFECTION CONTROL; POPULATION SURVEILLANCE; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC;

EID: 33749045859     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2006.03.008     Document Type: Article

References (46)

1. Catalano G., Houston S.H., Catalano M.C., Butera A.S., Jennings S.M., Hakala S.M., et al. Anxiety and depression in hospitalized patients in resistant organism isolation. South Med J 96 (2003) 141-145
2. Tarzi S., Kennedy P., Stone S., and Evans M. Methicillin-resistant Staphylococcus aureus: psychological impact of hospitalization and isolation in an older adult population. J Hosp Infect 49 (2001) 250-254
3. Evans H.L., Shaffer M.M., Hughes M.G., Smith R.L., Chong T.W., Raymond D.P., et al. Contact isolation in surgical patients: a barrier to care?. Surgery 134 (2003) 180-188
4. Stelfox H.T., Bates D.W., and Redelmeier D.A. Safety of patients isolated for infection control. JAMA 290 (2003) 1899-1905
5. Department of Health and Aging. Infection control guidelines for the prevention of transmission of infectious diseases in the health care setting. Australian Government: Department of Health and Aging, 2001. Available at: http://www.health.gov.au/internet/wcms/publishing.nsf/Content/icg-guidelines-index.htm. Accessed March 8, 2006.
6. CDC. Draft CDC guideline for isolation precautions: preventing transmission of infectious agents in health care settings. In: Committee HICPAC, ed. Federal Register 2004.
7. LeDell K., Muto C.A., Jarvis W.R., and Farr B.M. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 24 (2003) 639-641
8. Royal College of Nurses. Good practice for infection prevention and control. 2005. London. Available at: Wipe_it_out-good_practice_in_infection_prevention_and_control.pdf. Accessed March 7, 2006.
9. World Health Organization. Practical guidelines for infection control in healthcare facilities. Geneva: World Health Organization, 2003. Available at: http://whqlibdoc.who.int/wpro/2003/a82694.pdf. Accessed March 8, 2006.
10. In: Ducel G., Fabry J., and Nicolle L. (Eds). Prevention of hospital-acquired infections: A practical guide. 2nd ed. (2002), World Health Organization, Geneva. http://www.who.int/csr/resources/publications/drugresist/whocdscsreph200212.pdf Accessed March 8, 2006
11. Public Health Agency of Canada. Routine practices and additional precautions for preventing transmission in healthcare. Ottawa: Division of Nosocomial and Occupational Infections, Bureau of Infectious Diseases, Laboratory Centre for Disease Control, 1999. Available at: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/99vol25/25s4/index.html. Accessed March 8, 2006.
12. Hospital Infection Control Practices Advisory Committee HICPAC. Recommendations for preventing the spread of vancomycin resistance. Am J Infect Control 23 (1995) 87-94
13. Jampel H, Lubomski L, Friedman D. Treatment of coexisting cataract and glaucoma. Evidence Report/Technology Assessment Number 38. (Prepared by Johns Hopkins University Evidence-based Practice Center under Contract No. 290-97-0006.) AHRQ Publication No. 03-E041. Rockville, MD: Agency for Healthcare Research and Quality; June 2003.
14. Friedman D.S., Bass E.B., Lubomski L.H., Fleisher L.A., Kempen J.H., Magaziner J., et al. The methodologic quality of clinical trials on regional anesthesia for cataract surgery. Ophthalmology 108 (2001) 530-541
15. Cooper B.S., Stone S.P., Kibbler C.C., Cookson B.D., Roberts J.A., Medley G.F., et al. Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ 329 (2004) 533
16. In: Alderson P.G.S., and Higgins J.P.T. (Eds). Assessment of study quality. Cochrane reviewer's handbook 4.2.3 [Updated November 2004] (2004), John Wiley & Sons, Ltd, Chichester, UK
17. Trick W.E., Weinstein R.A., DeMarais P.L., Tomaska W., Nathan C., McAllister S.K., et al. Comparison of routine glove use and contact-isolation precautions to prevent transmission of multidrug-resistant bacteria in a long-term care facility. J Am Geriatr Soc 52 (2004) 2003-2009
18. Chaix C., Durand-Zaleski I., Alberti C., and Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 282 (1999) 1745-1751
19. Harris A.D., Bradham D.D., Baumgarten M., Zuckerman I.H., Fink J.C., and Perencevich E.N. The use and interpretation of quasi-experimental studies in infectious diseases. Clin Infect Dis 38 (2004) 1586-1591
20. Fazal B.A., Telzak E.E., Blum S., Turett G.S., Petersen-Fitzpatrick F.E., and Lorian V. Trends in the prevalence of methicillin-resistant Staphylococcus aureus associated with discontinuation of an isolation policy. Infect Control Hosp Epidemiol 17 (1996) 372-374
21. Srinivasan A., Song X., Ross T., Merz W., Brower R., and Perl T.M. A prospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant enterococci in an intensive care unit. Infect Control Hosp Epidemiol 23 (2002) 424-428
22. Lai K.K., Kelley A.L., Melvin Z.S., Belliveau P.P., and Fontecchio S.A. Failure to eradicate vancomycin-resistant enterococci in a university hospital and the cost of barrier precautions. Infect Control Hosp Epidemiol 19 (1998) 647-652
23. Cosseron-Zerbib M., Roque Afonso A.M., Naas T., Durand P., Meyer L., Costa Y., et al. A control programme for MRSA (methicillin-resistant Staphylococcus aureus) containment in a paediatric intensive care unit: evaluation and impact on infections caused by other micro-organisms. J Hosp Infect 40 (1998) 225-235
24. Cromer A.L., Hutsell S.O., Latham S.C., Bryant K.G., Wacker B.B., Smith S.A., et al. Impact of implementing a method of feedback and accountability related to contact precautions compliance. Am J Infect Control 32 (2004) 451-455
25. Kac G., Buu-Hoi A., Herisson E., Biancardini P., and Debure C. Methicillin-resistant Staphylococcus aureus: nosocomial acquisition and carrier state in a wound care center. Arch Dermatol 136 (2000) 735-739
26. Blumberg L.H., and Klugman K.P. Control of methicillin-resistant Staphylococcus aureus bacteraemia in high-risk areas. Eur J Clin Microbiol Infect Dis 13 (1994) 82-85
27. De Lucas-Villarrubia J.C., Lopez-Franco M., Granizo J.J., De Lucas-Garcia J.C., and Gomez-Barrena E. Strategy to control methicillin-resistant Staphylococcus aureus post-operative infection in orthopaedic surgery. Int Orthop 28 (2004) 16-20
28. Hartstein A.I., Denny M.A., Morthland V.H., LeMonte A.M., and Pfaller M.A. Control of methicillin-resistant Staphylococcus aureus in a hospital and an intensive care unit. Infect Control Hosp Epidemiol 16 (1995) 405-411
29. Montesinos I., Salido E., Delgado T., Lecuona M., and Sierra A. Epidemiology of methicillin-resistant Staphylococcus aureus at a university hospital in the Canary Islands. Infect Control Hosp Epidemiol 24 (2003) 667-672
30. Ostrowsky B.E., Trick W.E., Sohn A.H., et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 344 (2001) 1427-1433
31. Schelenz S., Tucker D., Georgeu C., Daly S., Hill M., Roxburgh J., et al. Significant reduction of endemic MRSA acquisition and infection in cardiothoracic patients by means of an enhanced targeted infection control programme. J Hosp Infect 60 (2005) 104-110
32. Winston L.G., Bangsberg D.R., Chambers III H.F., Felt S.C., Rosen J.I., Charlebois E.D., et al. Epidemiology of vancomycin-resistant Enterococcus faecium under a selective isolation policy at an urban county hospital. Am J Infect Control 30 (2002) 400-406
33. Siddiqui A.H., Harris A.D., Hebden J., Wilson P.D., Morris Jr. J.G., and Roghmann M.C. The effect of active surveillance for vancomycin-resistant enterococci in high-risk units on vancomycin-resistant enterococci incidence hospital-wide. Am J Infect Control 30 (2002) 40-43
34. Cepeda J.A., Whitehouse T., Cooper B., Hails J., Jones K., Kwaku F., et al. Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 365 (2005) 295-304
35. Muto C.A., Giannetta E.T., Durbin L.J., Simonton B.M., and Farr B.M. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant enterococcus. Infect Control Hosp Epidemiol 23 (2002) 429-435
36. Slaughter S., Hayden M.K., Nathan C., Hu T.C., Rice T., Van Voorhis J., et al. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 125 (1996) 448-456
37. Ribner B.S., Landry M.N., and Gholson G.L. Strict versus modified isolation for prevention of nosocomial transmission of methicillin-resistant Staphylococcus aureus. Infect Control 7 (1986) 317-320
38. Johnston P., Norrish A.R., Brammar T., Walton N., Hegarty T.A., and Coleman N.P. Reducing methicillin-resistant Staphylococcus aureus (MRSA) patient exposure by infection control measures. Ann R Coll Surg Engl 87 (2005) 123-125
39. Papia G., Louie M., Tralla A., Johnson C., Collins V., and Simor A.E. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost-effective?. Infect Control Hosp Epidemiol 20 (1999) 473-477
40. Jochimsen E.M., Fish L., Manning K., Young S., Singer D.A., Baker R., et al. Control of vancomycin-resistant enterococci at a community hospital: efficacy of patient and staff cohorting. Infect Control Hosp Epidemiol 20 (1999) 106-109
41. Misset B., Timsit J.F., Dumay M.F., Garrouste M., Chalfine A., Flouriot I., et al. A continuous quality-improvement program reduces nosocomial infection rates in the ICU. Intensive Care Med 30 (2004) 395-400
42. Wernitz M.H., Swidsinski S., Weist K., Sohr D., Witte W., Franke K.P., et al. Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections. Clin Microbiol Infect 11 (2005) 457-465
43. Silverblatt F.J., Tibert C., Mikolich D., Blazek-D'Arezzo J., Alves J., Tack M., et al. Preventing the spread of vancomycin-resistant enterococci in a long-term care facility. J Am Geriatr Soc 48 (2000) 1211-1215
44. Ioannidis J.P., Haidich A.B., Pappa M., Pantazis N., Kokori S.I., Tektonidou M.G., et al. Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 286 (2001) 821-830
45. Larson E.L.S.L., Haas J., Newmann A., Lowy F.D., Fatato B., and Bakken S.E. Perspectives on antimicrobial resistance: establishing an interdisciplinary research approach. Am J Infect Control 33 (2005) 410-418
46. Lynch P., Jackson M.M., Cummings M.J., and Stamm W.E. Rethinking the role of isolation practices in the prevention of nosocomial infections. Ann Intern Med 107 (1987) 243-246